We detected a strong activation profile of SARS-CoV-2-specific T cells only in COVID-19 patients, and this strong activation signature (high expression of CD38, CD39, PD1, HLA-DR) was further enhanced in patients requiring hospitalization. The gene discussed is ENTPD1; the disease is COVID-19.